Based on the existing research and our findings, we infer that HDAC1/REST interaction may participate in glioma and the mechanisms of miR-9-5p and miR-105-5p/HDAC1/REST axis in glioma are needed to be validated. This evidence concerns the gene REST and central nervous system cancer.